These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
101 related articles for article (PubMed ID: 25806909)
1. Value of combination of the neutrophil to lymphocyte ratio and platelet to lymphocyte ratio in primary percutaneous coronary intervention. Sertoglu E; Uyanik M Platelets; 2015; 26(8):814-5. PubMed ID: 25806909 [No Abstract] [Full Text] [Related]
2. Platelet to lymphocyte ratio as a prognostic marker in primary percutaneous coronary intervention. Ayça B; Akin F; Okuyan E Platelets; 2015; 26(8):816. PubMed ID: 25807323 [No Abstract] [Full Text] [Related]
3. Neutrophil-lymphocyte ratio and platelet-lymphocyte ratio combination can predict prognosis in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. Çiçek G; Açıkgoz SK; Bozbay M; Altay S; Uğur M; Uluganyan M; Uyarel H Angiology; 2015 May; 66(5):441-7. PubMed ID: 24834932 [TBL] [Abstract][Full Text] [Related]
4. Predictive Value of Combination of Neutrophil-Lymphocyte Ratio and Platelet-Lymphocyte Ratio for Prognosis. Eyüboğlu M Angiology; 2016 Feb; 67(2):195. PubMed ID: 26124492 [No Abstract] [Full Text] [Related]
5. Platelet to lymphocyte ratio as a prognostic marker in primary percutaneous coronary intervention. Ayça B; Akin F; Çelik Ö; Yüksel Y; Öztürk D; Tekiner F; Çetin Ş; Okuyan E; Dinçkal M H Platelets; 2015; 26(7):638-44. PubMed ID: 25350375 [TBL] [Abstract][Full Text] [Related]
6. Predictive value of admission red cell distribution width-platelet ratio for no-reflow phenomenon in acute ST segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. Celık T; Balta S; Demır M; Yıldırım AO; Kaya MG; Ozturk C; Demırkol S; Unlu M; Kılıc S; Aydın İ; Iyısoy A Cardiol J; 2016; 23(1):84-92. PubMed ID: 26503078 [TBL] [Abstract][Full Text] [Related]
7. Effect of Hematologic Parameters on Microvascular Reperfusion in Patients With ST-Segment Elevation Myocardial Infarction Treated With Primary Percutaneous Coronary Intervention. Karahan Z; Uçaman B; Uluğ AV; Aydınalp Ö; Uğurlu M; Çevik K; Kaya İ; Öztürk Ö Angiology; 2016 Feb; 67(2):151-6. PubMed ID: 26007233 [TBL] [Abstract][Full Text] [Related]
8. Predictors of No-Reflow Phenomenon in Young Patients With Acute ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention. Celik T; Balta S; Ozturk C; Kaya MG; Aparci M; Yildirim OA; Demir M; Unlu M; Demirkol S; Kilic S; Iyisoy A Angiology; 2016 Aug; 67(7):683-9. PubMed ID: 26369341 [TBL] [Abstract][Full Text] [Related]
9. The Utility of the Platelet-Lymphocyte Ratio for Predicting No Reflow in Patients With ST-Segment Elevation Myocardial Infarction. Yildiz A; Yuksel M; Oylumlu M; Polat N; Akyuz A; Acet H; Aydin M; Ülgen MS Clin Appl Thromb Hemost; 2015 Apr; 21(3):223-8. PubMed ID: 24431380 [TBL] [Abstract][Full Text] [Related]
10. Prognostic value of neutrophil to lymphocyte ratio in patients presenting with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention. Park JJ; Jang HJ; Oh IY; Yoon CH; Suh JW; Cho YS; Youn TJ; Cho GY; Chae IH; Choi DJ Am J Cardiol; 2013 Mar; 111(5):636-42. PubMed ID: 23273716 [TBL] [Abstract][Full Text] [Related]
12. A high or a reasonably-reactively elevated platelet-to-lymphocyte ratio, which plays the role? Meng X; Wang W; Wei G; Chang Q; He F; Ming L Platelets; 2016 Jul; 27(5):491. PubMed ID: 26764940 [No Abstract] [Full Text] [Related]
13. Predictive Value of Combination of NLR and PLR in the Absence of Medical Treatment. Çiçek G; Yayla Ç; Açıkgoz SK Angiology; 2016 Feb; 67(2):197. PubMed ID: 26251052 [No Abstract] [Full Text] [Related]
14. Combined Usefulness of the Platelet-to-Lymphocyte Ratio and the Neutrophil-to-Lymphocyte Ratio in Predicting the Long-Term Adverse Events in Patients Who Have Undergone Percutaneous Coronary Intervention with a Drug-Eluting Stent. Cho KI; Ann SH; Singh GB; Her AY; Shin ES PLoS One; 2015; 10(7):e0133934. PubMed ID: 26207383 [TBL] [Abstract][Full Text] [Related]
15. Association of Neutrophil-to-lymphocyte Ratio with Contrast-induced Nephropathy in Patients with Non-ST-elevation Acute Coronary Syndrome Treated with Percutaneous Coronary Intervention. Kurtul A; Yarlioglues M; Duran M; Murat SN Heart Lung Circ; 2016 Jul; 25(7):683-90. PubMed ID: 26935164 [TBL] [Abstract][Full Text] [Related]
16. Usefulness of the platelet-to-lymphocyte ratio in predicting bare-metal stent restenosis. Yılmaz S; Sen F; Ünal S; Yayla C; Özeke Ö; Aras D; Topaloglu S; Aydogdu S Scand Cardiovasc J; 2015 Feb; 49(1):39-44. PubMed ID: 25414124 [TBL] [Abstract][Full Text] [Related]
17. The neutrophil-to-lymphocyte ratio is associated with bare-metal stent restenosis in STEMI patients treated with primary PCI. Bolca O; Güngör B; Özcan KS; Karadeniz FÖ; Sungur A; Köroğlu B; Bakhshyaliyev N; Yelgeç NS; Karataş B; İpek G; Yilmaz H; Öztürk R Coron Artery Dis; 2015 Aug; 26(5):402-8. PubMed ID: 25919903 [TBL] [Abstract][Full Text] [Related]
18. The prognostic value of admission mean platelet volume to platelet count ratio in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. Bolat I; Akgul O; Cakmak HA; Pusuroglu H; Somuncu U; Ozbey S; Ornek V; Erturk M; Gul M Kardiol Pol; 2016; 74(4):346-55. PubMed ID: 26365942 [TBL] [Abstract][Full Text] [Related]
19. Incorporating Neutrophil-to-lymphocyte Ratio and Platelet-to-lymphocyte Ratio in Place of Neutrophil Count and Platelet Count Improves Prognostic Accuracy of the International Metastatic Renal Cell Carcinoma Database Consortium Model. Chrom P; Stec R; Bodnar L; Szczylik C Cancer Res Treat; 2018 Jan; 50(1):103-110. PubMed ID: 28253564 [TBL] [Abstract][Full Text] [Related]
20. Correlation of platelet-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio with thrombolysis in myocardial infarction frame count in ST-segment elevation myocardial infarction. Vakili H; Shirazi M; Charkhkar M; Khaheshi I; Memaryan M; Naderian M Eur J Clin Invest; 2017 Apr; 47(4):322-327. PubMed ID: 28177528 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]